DEXWireNews

Durect Corp bounces off Support

NASDAQ:DRRX   DURECT Corporation
DURECT Corp. is a biopharmaceutical company, which engages in the research, development, and manufacturing of pharmaceutical products. The company products include alzet and lactel. Its pipeline includes DUR-928, which focuses on lipid homeostasis, inflammation, and cell survival; and POSIMIR, which is an analgesic product intended to deliver bupivacaine to provide pain relief after surgery. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.

#1 News Source For Stock & Crypto Traders

1) Sign Up for our Free Email Newsletter:
dexwirenews.com/sign-up/

2) Follow Us on Telegram @ t.me/DEXWireNews

3) Subscribe to our YouTube Channel @ youtube.com/@DEXWireNews
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.